IGF1 and obstructive sleep apnea syndrome: We checked the serum IGF-1 concentration in 16 studies using chemiluminescence and found that serum IGF-1 concentrations in patients with OSAHS were greatly reduced compared with those of subjects in the control group (SMD=-0.74, 95%CI= -1.04–0.43, P< 0.001).